EXOSC5: a novel biomarker for poor prognosis in lung adenocarcinoma
EXOSC5 is a novel oncogenic factor in LUAD that promotes tumor progression and immune evasion and may serve as a prognostic biomarker and therapeutic target.
Authors
- Fengmei Guo (ORCID: https://orcid.org/0000-0001-7472-3795)
- Zhen Yang (ORCID: https://orcid.org/0000-0003-0225-7099)
- Zhengwei Zhang (ORCID: https://orcid.org/0000-0002-5376-8537)
- Jianxun Xu (ORCID: https://orcid.org/0000-0002-5396-1134)
- Keyao Han
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1186/s12885-025-14059-2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00